Mónica L. Guzmán
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 69
- Hematopoietic Stem Cell Transplantation 12
- Chronic Myeloid Leukemia Treatments 10
- Cancer Research top 0.5%
- Oncology top 1%
- CAR-T cell therapy research 18
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Molecular Biology top 1%
- Histone Deacetylase Inhibitors Research 15
- Protein Degradation and Inhibitors 10
-
- Acute Lymphoblastic Leukemia research 12
- Co-authors
- Craig T. JordanMark NobleDianna S. HowardRandall M. RossiDuane C. HassaneGail J. RobozBarry GrimesSarah J. Neering
- Cited by
- HematologyCancer ResearchOncology
- Partner nations
- United StatesMexicoIsrael
In The Last Decade
Mónica L. Guzmán
140 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Hematology 2.2k
- Cancer Research 1.7k
- Oncology 2.2k
- Genetics 777
- Molecular Biology 4.2k
Countries citing papers authored by Mónica L. Guzmán
This map shows the geographic impact of Mónica L. Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica L. Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica L. Guzmán more than expected).
Fields of papers citing papers by Mónica L. Guzmán
This network shows the impact of papers produced by Mónica L. Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica L. Guzmán. The network helps show where Mónica L. Guzmán may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mónica L. Guzmán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 15 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 22 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 12 | |
| 13 | 2018 | 58 | |
| 14 | 2017 | 60 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 166 | |
| 17 | 2016 | 13 | |
| 18 | 2014 | 45 | |
| 19 | 2008 | 145 | |
| 20 | 2002 | 334 |
About Mónica L. Guzmán
Mónica L. Guzmán is a scholar working on Hematology, Cancer Research and Genetics, having authored 150 papers that have together received 7.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (69 papers), CAR-T cell therapy research (18 papers), Histone Deacetylase Inhibitors Research (15 papers), Hematopoietic Stem Cell Transplantation (12 papers), Acute Lymphoblastic Leukemia research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Hematology (2.2k citations), Cancer Research (1.7k citations) and Oncology (2.2k citations). Mónica L. Guzmán has collaborated with scholars based in United States, Mexico and Israel. Frequent co-authors include Craig T. Jordan, Mark Noble, Dianna S. Howard, Randall M. Rossi, Duane C. Hassane, Gail J. Roboz, Barry Grimes, Sarah J. Neering, Selina M. Luger and David A. Rizzieri. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.